News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
329
Sources here
19
Companies here
11
Search results Stored financial headlines

Active search

329 matching headlines

Ticker or company: HIOMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Byrna, Lucid, Park-Ohio, JELD-WEN, and Tesla Shares Skyrocket, What You Need To Know

Byrna, Lucid, Park-Ohio, JELD-WEN, and Tesla Shares Skyrocket, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after the July jobs report showed an unexpected loss of 23,000 jobs, signaling a cooling labor market. Economists had forecast …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park-Ohio Holdings Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PKOH) 2026-08-10

Park-Ohio Holdings Corp. (NASDAQ: PKOH) published its Q2 2026 earnings call presentation on August 10, 2026. The company reported an EPS of $0.93, beating estimates by $0.12, and revenue of $440.10M, surpassing expectations by $12.83M with a 10.00% year-over-year increase. This presentation provides details …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stonegate Capital Partners Updates Coverage on Park-Ohio Holdings Corp. (PKOH) 2Q26

Stonegate Capital Partners has updated its coverage on Park-Ohio Holdings Corp. (PKOH) for 2Q26, noting a significant improvement in its portfolio with higher-margin, more durable businesses driving growth. The company reported increased revenue, expanded gross margin, and improved operating income, leading management to raise …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio Pharmaceuticals Corp (PHIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Phio Pharmaceuticals Corp (PHIO) has an earnings forecast score of 8.00, placing it 171st out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $14.00 for PHIO, with a strong buy recommendation based on the rating …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park Ohio Holdings Corp (PKOH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Park Ohio Holdings Corp (PKOH), highlighting its current earnings forecast score of 8.00 within its industry. Based on analysis from one analyst, the stock is rated as a "Buy" with a target price indicating a 2.84% upside. …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ohio Valley Banc Corp (OVBC) Stock News Today

This page provides current news and analysis for Ohio Valley Banc Corp (OVBC) stock, including its latest stock price, market cap, and P/E ratio. As of the latest update, the stock was trading at $43.560, down 0.39%. The platform states that more news will …

OVBC main company
Sharemaestro market context Price above Trend Line 52 weeks +25.0% OVBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PHIO: PH-762 clinical progress accelerates as cash runway extends into 2027 amid rising R&D costs

Phio Pharmaceuticals (PHIO) is advancing its PH-762 clinical program with ongoing key studies and preparations for FDA submission. The company's financial position is projected to support operations until late 2027, despite an increase in R&D expenses and a higher net loss compared to the …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio Pharmaceuticals Corp. Q2 2026: Net income $(4.14)M, EPS $(0.36) — 10-Q Summary

Phio Pharmaceuticals Corp. reported a net loss of $(4.14)M and diluted EPS of $(0.36) for Q2 2026, remaining pre-revenue. Key highlights include the completion of PH-762 Phase 1b trial enrollment with promising results in cSCC, initiation of cGMP drug substance manufacturing, and a planned …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lulu's Fashion Lounge Holdings Inc (LVLU) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Lulu's Fashion Lounge Holdings Inc (LVLU), indicating that no earnings forecast score is currently available. It highlights an average price target of $1.00 from zero analysts, suggesting a 143.37% upside space. The report also includes a peer …

LVLU main company
Sharemaestro market context Price above Trend Line 52 weeks +292.0% LVLU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lulus Fashion Lounge (LVLU.US) will release its earnings report after market close on August 12.

Lulus Fashion Lounge (LVLU.US) is scheduled to release its earnings report after the market closes on August 12. This announcement indicates an upcoming financial disclosure for the company.

LVLU main company
Sharemaestro market context Price above Trend Line 52 weeks +292.0% LVLU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

KeyBanc Maintains Park-Ohio Holdings Corp(PKOH.US) With Buy Rating, Raises Target Price to $59

KeyBanc has reiterated its Buy rating for Park-Ohio Holdings Corp (PKOH.US) and increased the target price to $59. This indicates a positive outlook from the analyst firm regarding the company's stock performance.

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio Pharmaceuticals posts $4.1M Q2 net loss, cash $13.0M; advances PH-762 program

Phio Pharmaceuticals reported a net loss of $4.1 million for Q2 2026, with $13.0 million in cash and cash equivalents, expected to fund operations into the second half of 2027. The company is advancing its lead INTASYL candidate, PH-762, having completed a Phase 1b …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park-Ohio Holdings Corp (PKOH) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...

Park-Ohio Holdings Corp (PKOH) reported record consolidated revenues of $440 million for Q2 2026, a 10% increase year-over-year, driven by strong demand in semiconductor, AI data center, aerospace, and electrical infrastructure markets. The company raised its full-year 2026 guidance for net sales, adjusted EPS, …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lulu’s Fashion Lounge Regains Nasdaq Listing Compliance Status

Lulu’s Fashion Lounge Holdings, Inc. (LVLU) has announced that it has regained compliance with Nasdaq's continued listing requirements. This was achieved by meeting the alternative market value of listed securities standard of at least $35 million, which the company maintained for ten consecutive business …

LVLU main company
Sharemaestro market context Price above Trend Line 52 weeks +292.0% LVLU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Phio Pharmaceuticals Corp. reported its second-quarter 2026 financial results, highlighting significant progress in its PH-762 development program, including the initiation of commercial scale API production and a long-term non-clinical toxicology study. The company completed its Phase 1b clinical trial for PH-762 and plans to …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio intends to request an FDA meeting after 22-patient cancer study

Phio Pharmaceuticals reported its Q2 2026 financial results, including a net loss of $4.1 million and cash and equivalents of $13.0 million, which is expected to fund operations into the second half of 2027. The company completed a 22-patient Phase 1b trial for its …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park-Ohio Holdings (PKOH) CEO details 8,810-share tax disposition

Park-Ohio Holdings CEO Matthew V. Crawford reported an F-code disposition of 8,810 shares of Common Stock on August 6, 2026, to cover tax obligations at $39.93 per share. Following this transaction, he directly holds 895,077 shares, with additional indirect interests through various trusts and …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park Ohio (PKOH) CFO delivers 3,670 shares for option or tax payment

Park Ohio Holdings Corp. CFO Patrick W. Fogarty reported a disposition of 3,670 shares of common stock on August 5, 2026. These shares were delivered or withheld to cover an exercise price or tax liability, not as a traditional market sale. Following this transaction, …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PARK OHIO HOLDINGS CORP 2026: Revenue $440.1M, Net income $12.1M, EPS $0.86— 10-Q Summary

PARK OHIO HOLDINGS CORP (PKOH) reported strong quarterly results for 2026, with revenue increasing to $440.1M and net income reaching $12.1M, resulting in a diluted EPS of $0.86. These improvements were driven by heightened demand across various sectors including semiconductor, AI data center, defense, …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Park-Ohio tops Q2 2026 estimates and raises outlook

Park-Ohio Holdings Corp. (PKOH) exceeded Q2 2026 earnings and revenue estimates, reporting adjusted EPS of $0.93 and record revenue of $440 million, driven by strong demand across industrial sectors like semiconductors, AI data centers, and aerospace. The company raised its full-year 2026 guidance for …

PKOH main company
Sharemaestro market context Trend signal active 52 weeks +151.4% PKOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context